Most patients in both groups were still treated with glucocorticoids, other immunosuppressant agents and blood pressure lowering drugs ... study did not received external funding or sponsorship. All ...

DMTs are drugs to improve the long-term outlook of the condition ... anti-inflammatory corticosteroid like Solu-Medrol (methylprednisolone) or prednisone. The symptoms of MS, like fatigue, bladder ...

Methods: The study group comprised patients with RA treated with conventional disease-modifying drugs with or without rituximab ... two infusions of 1000 mg each along with 100 mg methylprednisolone ...

Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms, according to an international study involving the ...

Some common GLP-1 drugs include Ozempic and Wegovy, which contain semaglutide as the active ingredient, and Mounjaro and Zepbound, which contain tirzepatide. In the study, nine patients who were ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

The study was small — just 48 adults — and lasted just over two months, so it’s not the final word. Experts say it’s not yet clear how safe these drugs are for people who don’t need to ...

Novo Nordisk announced plans for a longer phase III trial testing its investigational obesity drug CagriSema, with regulatory submission expected early next year. The FDA approved ranibizumab (Susvimo ...

The study evaluates MRK’s pulmonary arterial hypertension (PAH) drug, Winrevair (sotatercept), for a more advanced version of the disease. This decision is based on strong efficacy data from ...

A new study conducted by researchers from the University of Southern California looked at a positive side effect of drugs like Ozempic and Wegovy – a reduction in alcohol consumption.